An observational study in Critical Illness, sponsored by Orion Corporation, Orion Pharma. Terminated at 3 sites in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-09-06.
Sponsored by Orion Corporation, Orion Pharma · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to determine whether the use of different sedatives affect the weaning process from mechanical ventilation in intensive care patients.
Traditionally patients with ongoing mechanical ventilation have been sedated to assure absence of pain, anxiety and to provide comfort. Unfortunately this approach might have negative consequences such as prolonged time for mechanical ventilation, length of stay in the ICU and hospital.
In this study, the investigators would like to investigate (in an exploratory way due to the non-interventional setup) whether weaning from mechanical ventilation will be affected by the choice of sedatives - including dexmedetomidine, midazolam and propofol. This study also aims at investigating how the choice of primary sedative will affect delirium/anxiety, need of other medications (sedatives, analgesics, anti-psychotics), quality of life after ICU and the presence of Post-Traumatic Stress Disorder. In addition, the investigators aim at receiving information from the caregivers on their ICU experience, as recent data imply that not only the ICU patient but also the caregiver suffer from PTSD after the ICU stay.
1,787 studies on the registry are indexed under Critical Illness; 445 are open to participants now.
This study's enrollment of 155 is above the median of 140 across 816 observational studies indexed under Critical Illness.
Browse Critical Illness studies →Orion Corporation, Orion Pharma is the lead sponsor of 101 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult general intensive care patients Need of mechanical ventilation >24 hours Need of light to moderate sedation
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Here, patients to be included are those being sedated with dexmedetomidine as primary sedative.
Other: SOC
Here, patients to be included are those being sedated with propofol as primary sedative.
Other: SOC
Here, patients to be included are those being sedated with midazolam as primary sedative
Other: SOC
Patient are given standard of care
The time point from when the patient is considered "fit for weaning" to the actual time point for extubation
Time frame: 30 days
Time-point for patient being considered "fit for extubation"
Time frame: 30 days
Total time in mechanical ventilation
Time frame: 30 days
Extubation failure (re-intubation within 24 hours)
Time frame: 24 hours
Anxiety/delirium assessments
RASS/MAAS sedation scales and ICDSC/CAM-ICU delirium assessments methods are used, as appropriate
Time frame: 30 days
Length of ICU stay (actual time of discharge)
Time frame: 30 days
QoL (15D)
Time frame: 2-4 months post-ICU discharge
Post-Traumatic Stress Disorder assessment - PTSS14 questionnaire
This assessment will be offered to the ICU patients but also to their caregivers.
Time frame: 2-4 months post-ICU discharge
Total duration of sedation
Time frame: 30 days
Number of days using opioids
Time frame: 30 days
Number of days using antipsychotic/neuroleptic drugs
Time frame: 30 days
Plan to share: No
Ran from Jun 2012 to primary completion in Nov 2015, 41 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Orion Corporation, Orion Pharma →